Catalio Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001958125 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $477M (100.0% shares, 0.0% debt)

Holdings (40)

LLY ELI LILLY & CO 8.8%
Value $42.03M Shares 53,916 Est. Cost $796.81 Unrealized -2.9%
BBIO BRIDGEBIO PHARMA INC 8.4%
Value $40.06M Shares 927,711 Est. Cost $26.37 Unrealized +37.9%
SLNO SOLENO THERAPEUTICS INC 7.2%
Value $34.35M Shares 409,944 Est. Cost $64.58 Unrealized +15.9%
ASND ASCENDIS PHARMA A/S 6.5%
Value $31.06M Shares 179,926 Est. Cost $137.67 Unrealized
ISRG INTUITIVE SURGICAL INC 6.5%
Value $30.8M Shares 56,674 Est. Cost $521.57 Unrealized +0.2%
EW EDWARDS LIFESCIENCES CORP 6.4%
Value $30.57M Shares 390,932 Est. Cost $70.36 Unrealized +6.0%
GILD GILEAD SCIENCES INC 5.3%
Value $25.15M Shares 226,875 Est. Cost $104.39 Unrealized 0.0%
BSX BOSTON SCIENTIFIC CORP 5.2%
Value $24.6M Shares 229,046 Est. Cost $101.18 Unrealized 0.0%
CYTK CYTOKINETICS INC 4.2%
Value $19.87M Shares 601,439 Est. Cost $50.21 Unrealized -30.7%
SNDX SYNDAX PHARMACEUTICALS INC 4.1%
Value $19.71M Shares 2,104,512 Est. Cost $13.56 Unrealized -18.8%
TEVA TEVA PHARMACEUTICAL INDS LTD 4.1%
Value $19.62M Shares 1,170,372 Est. Cost $16.76 Unrealized
CORT CORCEPT THERAPEUTICS INC 3.7%
Value $17.55M Shares 239,125 Est. Cost $72.50 Unrealized 0.0%
NTRA NATERA INC 3.4%
Value $16.44M Shares 97,297 Est. Cost $155.83 Unrealized 0.0%
ADPT ADAPTIVE BIOTECHNOLOGIES COR 3.4%
Value $16.27M Shares 1,396,445 Est. Cost $8.47 Unrealized +7.2%
DNTH DIANTHUS THERAPEUTICS INC 2.9%
Value $13.91M Shares 746,527 Est. Cost $25.71 Unrealized -27.0%
GPCR STRUCTURE THERAPEUTICS INC 2.9%
Value $13.91M Shares 670,575 Est. Cost $25.23 Unrealized
ADMA ADMA BIOLOGICS INC 2.2%
Value $10.37M Shares 569,704 Est. Cost $20.39 Unrealized 0.0%
HALO HALOZYME THERAPEUTICS INC 2.1%
Value $9.963M Shares 191,529 Est. Cost $56.90 Unrealized 0.0%
RARE ULTRAGENYX PHARMACEUTICAL IN 1.6%
Value $7.759M Shares 213,402 Est. Cost $36.05 Unrealized 0.0%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 1.6%
Value $7.675M Shares 162,596 Est. Cost $42.39 Unrealized -3.9%
PHAT PHATHOM PHARMACEUTICALS INC 1.4%
Value $6.447M Shares 672,290 Est. Cost $5.53 Unrealized 0.0%
QURE UNIQURE NV 1.2%
Value $5.819M Shares 417,443 Est. Cost $8.63 Unrealized +55.8%
WGS GENEDX HOLDINGS CORP 1.2%
Value $5.678M Shares 61,507 Est. Cost $78.50 Unrealized 0.0%
TARA PROTARA THERAPEUTICS INC 1.0%
Value $4.928M Shares 1,626,370 Est. Cost $3.30 Unrealized +4.4%
OM OUTSET MED INC 0.7%
Value $3.202M Shares 166,666 Est. Cost $11.92 Unrealized +30.9%
SEPN SEPTERNA INC 0.7%
Value $3.111M Shares 294,360 Est. Cost $23.65 Unrealized -65.2%
REPL REPLIMUNE GROUP INC 0.6%
Value $3.069M Shares 330,337 Est. Cost $12.38 Unrealized -29.5%
ZBIO ZENAS BIOPHARMA INC 0.4%
Value $2.086M Shares 215,314 Est. Cost $12.75 Unrealized -23.6%
VIR VIR BIOTECHNOLOGY INC 0.4%
Value $1.957M Shares 388,303 Est. Cost $8.89 Unrealized -39.7%
KYTX KYVERNA THERAPEUTICS INC 0.4%
Value $1.802M Shares 586,909 Est. Cost $4.79 Unrealized -48.4%
IRON DISC MEDICINE INC 0.3%
Value $1.624M Shares 30,661 Est. Cost $46.97 Unrealized 0.0%
FULC FULCRUM THERAPEUTICS INC 0.3%
Value $1.296M Shares 188,304 Est. Cost $3.67 Unrealized +45.6%
BCAX BICARA THERAPEUTICS INC 0.2%
Value $909K Shares 97,800 Est. Cost $11.92 Unrealized 0.0%
MGX METAGENOMI INC 0.2%
Value $783K Shares 528,993 Est. Cost $2.41 Unrealized -35.1%
KPTI KARYOPHARM THERAPEUTICS INC 0.1%
Value $629K Shares 146,013 Est. Cost $8.54 Unrealized -42.5%
HYPR HYPERFINE INC 0.1%
Value $547K Shares 760,035 Est. Cost $0.96 Unrealized -27.1%
MERSANA THERAPEUTICS INC 0.1%
Value $464K Shares 1,567,413 Est. Cost $1.43 Unrealized
ATAI LIFE SCIENCES NV 0.1%
Value $431K Shares 196,858 Est. Cost $1.33 Unrealized
GUTS FRACTYL HEALTH INC 0.1%
Value $347K Shares 214,236 Est. Cost $2.33 Unrealized -30.6%
SNSE SENSEI BIOTHERAPEUTICS INC 0.0%
Value $126K Shares 14,718 Est. Cost $7.18 Unrealized 0.0%